XSDR:LSE Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C

GBX 20,267.50 20.00 0.098778
Icon

Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C (XSDR:LSE) Stock Analysis and Price Targets

ETF | Others | LSE
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

GBX 20,267.50

+20.00 (+0.10)%

GBX 0.16B

N/A

N/A

N/A

Icon

XSDR:LSE

Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C (GBX)
ETF | LSE
GBX 20,267.50
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

GBX 0.16B

N/A

GBX 20,267.50

Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C (XSDR:LSE) Stock Forecast

N/A

Based on the Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C stock forecast from 0 analysts, the average analyst target price for Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C is not available over the next 12 months. Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C is Very Bullish, which is based on 2 positive signals and 0 negative signals. At the last closing, Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C’s stock price was GBX 20,267.50. Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C’s stock price has changed by +0.32% over the past week, -0.09% over the past month and +22.60% over the last year.

No recent analyst target price found for Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C
No recent average analyst rating found for Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C

Company Overview Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C

NA

http://www.dws.lu

N/A

N/A

N/A

GBX

UK

N/A

N/A

N/A

0.17 %

Adjusted Closing Price for Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C (XSDR:LSE)

Loading...

Unadjusted Closing Price for Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C (XSDR:LSE)

Loading...

Share Trading Volume for Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C Shares

Loading...

Compare Performance of Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for XSDR:LSE

Top Sectors

N/A

Top Regions

N/A

Valuation Growth & Performance

  • 4

  • Morningstar Gbl Health TME ...

  • 4

  • 10.65

  • 10.55

  • 0.68

  • 13.56%

  • 9.15%

  • 9.58%

  • 0%

Stocks Similar To Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C (Sector: Others )

Symbol Name Mer Price(Change) Market Cap
XNID:LSE
Xtrackers Nifty 50 Swap UCITS .. 0.85 % +1.10 (+0.39%) GBX292,109.69B

ETFs Containing XSDR

Symbol Name XSDR's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C (XSDR:LSE) Stock

Stock Target Advisor's fundamental analysis for Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C's stock is Very Bullish.

XSDR:LSE stock's dividend yield is 2.60%. Our analysis grades XSDR:LSE stock's dividend yield at F. This means that XSDR:LSE stock's dividend yield is above 39% of the stocks in the Others sector in the LSE exchange. Based on this XSDR:LSE may be a poor dividend stock for its sector.

Unfortunately we do not have enough data on XSDR:LSE's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on XSDR:LSE's stock to indicate if its overvalued.

The last closing price of XSDR:LSE's stock was GBX 20,267.50.

The most recent market capitalization for XSDR:LSE is GBX 0.16B.

Unfortunately we do not have enough analyst data on XSDR:LSE's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C's stock.

Sorry, we do not have any data on the number of employees for Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C.

Sorry we do not have any infomation available on Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C's address.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...